0.05Open0.05Pre Close0 Volume7 Open Interest2.50Strike Price0.00Turnover158.10%IV62.42%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1741Delta0.4042Gamma31.40Leverage Ratio-0.0034Theta0.0001Rho5.47Eff Leverage0.0010Vega
Aadi Biosciences Stock Discussion
NEWS
Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting
Aadi Bioscience presented new nonclinical data at the ASCO Annual Meeting showing that nab-sirolimus achieved higher intratumoral drug concentrations, stronger mTOR target inhibition, and greater antitumor activity compared to IV and oral mTOR inhibitors in a xenograft model. These findings suppo...
$Envoy Medical(COCH.US)$ $CXApp(CXAI.US)$ $Aadi Biosciences(AADI.US)$ $CURO Group(CURO.US)$ $BigBear.ai Holdings(BBAI.US)$ $Fisker(FSR.US)$ $Ainos(AIMD.US)$
📊⚡️📊
• $Red Robin(RRGB.US)$ +13.8% (In reaction to earnings)
• $PMV Pharmaceuticals(PMVP.US)$ +11.2% (ASCO-related announcement)
• $Sumo Logic(SUMO.US)$ +10.8% (In reaction to earnings)
• $Adicet Bio(ACET.US)$ +9.6% (ASCO-related announcement)
• $Dell Technologies(DELL.US)$ +9.6% (In reaction to earnings)
• $ImmunoGen(IMGN.US)$ +8.7% (ASCO-related announcement)
• $Ulta Beauty(ULTA.US)$ +7.9% (In reaction to earnings)
• $Zymergen(ZY.US)$ +7.8% (to...
No comment yet